Literature DB >> 11013121

Angiotensin II induces nuclear factor- kappa B activation in cultured neonatal rat cardiomyocytes through protein kinase C signaling pathway.

P Rouet-Benzineb1, B Gontero, P Dreyfus, C Lafuma.   

Abstract

Rat neonatal ventricular cardiomyocytes (RNVM) possess G protein-coupled AT(1)receptors for angiotensin II (AngII) that activate multiple intracellular pathways. To elucidate potential signaling mechanisms involved, we focussed on the nuclear transcription factor-kappa B (NF- kappa B) in RNVM culture. Using specific antibody to NF- kappa Bp65, immunolocalization of NF- kappa B was cytoplasmic in unstimulated cardiomyocytes, whereas NF- kappa B was translocated into the RNVM nucleus in response to AngII. This translocation was inhibited in the presence of calphostin C, a specific inhibitor of protein kinase C (PKC). Western blot analysis showed an increase of NF- kappa B in AngII-stimulated cardiomyocyte nuclear extracts as compared to controls. Biomolecular interaction analysis (BIA analysis) of NF- kappa B activation showed that only AngII-nuclear extracts bound to NF- kappa B consensus sequence with a high degree of affinity. This DNA-binding capacity was completely lost in calphostin C-treated cells. At transcriptional level in RNVM, AngII mediates the upregulation of matrix gelatinase (MMP-9), which is totally inhibited by calphostin C treatment. In conclusion, cardiomyocyte nuclear NF- kappa B translocation in response to Ang II via PKC pathway activates cardiomyocyte-specific transcription of MMP-9 and may activate transcription from responsive genes which are involved in cardiac hypertrophy process and/or cardiac remodeling. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11013121     DOI: 10.1006/jmcc.2000.1211

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  28 in total

Review 1.  Clinical implications of matrix metalloproteinases.

Authors:  Malay Mandal; Amritlal Mandal; Sudip Das; Tapati Chakraborti; Chakraborti Sajal
Journal:  Mol Cell Biochem       Date:  2003-10       Impact factor: 3.396

Review 2.  Matrix metalloproteinases: pathways of induction by bioactive molecules.

Authors:  Toshihiro Tsuruda; Lisa C Costello-Boerrigter; John C Burnett
Journal:  Heart Fail Rev       Date:  2004-01       Impact factor: 4.214

Review 3.  Tear me down: role of calpain in the development of cardiac ventricular hypertrophy.

Authors:  Cam Patterson; Andrea L Portbury; Jonathan C Schisler; Monte S Willis
Journal:  Circ Res       Date:  2011-08-05       Impact factor: 17.367

4.  NF-κB-mediated miR-30b regulation in cardiomyocytes cell death by targeting Bcl-2.

Authors:  Chuanyu Wei; Li Li; Sudhiranjan Gupta
Journal:  Mol Cell Biochem       Date:  2013-11-01       Impact factor: 3.396

5.  Loss of STAT1 is associated with increased aortic rupture in an experimental model of aortic dissection and aneurysm formation.

Authors:  Matthew J Eagleton; Jun Xu; Mingfang Liao; Brittney Parine; Guy M Chisolm; Linda M Graham
Journal:  J Vasc Surg       Date:  2010-04       Impact factor: 4.268

Review 6.  Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities.

Authors:  Jason J Gajarsa; Robert A Kloner
Journal:  Heart Fail Rev       Date:  2011-01       Impact factor: 4.214

Review 7.  Assigning matrix metalloproteinase roles in ischaemic cardiac remodelling.

Authors:  Merry L Lindsey
Journal:  Nat Rev Cardiol       Date:  2018-08       Impact factor: 32.419

8.  Do multiple nuclear factor kappa B activation mechanisms explain its varied effects in the heart?

Authors:  Rajesh Kumar; Qian Chen Yong; Candice M Thomas
Journal:  Ochsner J       Date:  2013

9.  Docosahexaenoic acid inhibits protein kinase C translocation/activation and cardiac hypertrophy in rat cardiomyocytes.

Authors:  Alicia Castillo; Nargiz Ruzmetov; Kevin A Harvey; William Stillwell; Gary P Zaloga; Rafat A Siddiqui
Journal:  J Mol Genet Med       Date:  2005-07-28

10.  Expression of toll-like receptor 4, tumor necrosis factor- alpha, matrix metalloproteinase-9 and effects of benazepril in patients with acute coronary syndromes.

Authors:  Ping Xie; Yun-Shan Cao; Peng Su; Yu-Hong Li; Zhi-Ling Gao; Mathias M Borst
Journal:  Clin Med Insights Cardiol       Date:  2010-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.